Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Junshi Biosciences Co., Ltd. has announced the election of Mr. Li Zhongxian and Ms. Lu Kun as independent non-executive directors, effective December 20, 2024. Both appointments were approved during the Extraordinary General Meeting, with each director set to receive an annual fee of RMB200,000. These changes are part of a strategic shift in the company’s audit and strategic committees.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.